4th Quarter - Report

CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 17, 2014 $20,000 Replaced
4th Quarter - Report (this page) Jan 17, 2014 $30,000 Replaced
4th Quarter - Amendment Jan 22, 2014 $30,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Board on the Hill lobby day, Affordable Care Act Implementation, Medicaid, Medicare, budget and appropriations, National Institutes of health and Food and Drug Administration funding, HR 2725 the FDA SOS Act

LobbyistCovered position, as disclosed
ERIC CHAMBERLAIN —
MARY B DWIGHT Legislative Correspondent, Legislative Assistant
JACQUELINE ERDO —
STEPHANIE KRENRICH Sr. Leg. Asst.; Leg. Asst.; Leg. Aide; Leg. Corr.

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Social Security Administration (SSA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2725 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.